We will participate in Medlab Middle East from 3 to 6 February 2025, an event showcasing the future of laboratory technology.

A warm welcome awaits you at our stand Z1.C30. at the Dubai World Trade Center.

At our stand:

• Discover new products
• Learn from our experts about how the next generation of non-invasive diagnostic solutions can make your business more efficient, save costs and improve the patient experience.
• Our experts will present our family of products for the gastrointestinal tract and answer your questions.

This major event brings together global leaders, innovators, and industry experts to discover ground-breaking inventions, cutting-edge solutions and valuable networking opportunities.

Find out more at Medlab Middle East.

Biohit Oyj is a Finnish biotechnology company operating on global markets. Our mission, “Innovating for Health”, describes our innovative products and services, which aim to promote medical research and early diagnosis, and prevent serious illnesses.

Our goal is to improve people’s quality of life by preventing diseases, human suffering, and financial loss. Biohit is headquartered in Helsinki and has subsidiaries located in Italy and the United Kingdom. Biohit’s Series B shares (BIOBV) are listed in Nasdaq OMX Helsinki Small Cap group and in the healthcare sub-sector.